Rostrum Medical announces the publication of initial validation results of its novel VQm® System

Management of mechanically ventilated patients can be complex due to the difficulty in directly assessing the impacts to the heart and lung following clinical interventions. Rostrum Medical recently announced the publication of initial validation results of its VQm® System, designed and developed to address these challenges in patient management.

Rostrum Medical is an EAHN™ company and presented at the OBIO® Investment Summit.

Previous
Previous

Vital Biosciences introduces revolutionary point-of-care lab testing platform & raises $48 million

Next
Next

Retispec’s innovative AI technology transforming Alzheimer’s disease screening